Spots Global Cancer Trial Database for adenosquamous cell lung cancer
Every month we try and update this database with for adenosquamous cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation | NCT02264210 | Lung Neoplasms Squamous Cell L... Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Bronchial Neopl... Stage IB Non-sm... | Icotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | NCT00551369 | Lung Cancer | SBRT | 18 Years - | Radiation Therapy Oncology Group | |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy | NCT01208064 | Lung Cancer | pazopanib hydro... laboratory biom... pharmacogenomic... pharmacological... quality-of-life... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003202 | Lung Cancer | cisplatin gemcitabine hyd... radiation thera... | - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | NCT05292859 | Gynecologic Can... Colorectal Canc... Pancreatic Canc... Non-small Cell ... Cholangiocarcin... Ovarian Cancer Ovary Neoplasm Squamous Cell L... Adenocarcinoma ... Adenosquamous C... | Neoantigen spec... | 18 Years - | Alaunos Therapeutics | |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | NCT00093132 | Carcinoma, Non-... Lung Cancer | Satraplatin | 18 Years - | Agennix | |
| SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002642 | Lung Cancer | cisplatin etoposide conventional su... low-LET cobalt-... | 18 Years - | SWOG Cancer Research Network | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00798603 | Lung Cancer | bevacizumab carboplatin pemetrexed diso... | 70 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | NCT00002852 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... | paclitaxel carboplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00346320 | Lung Cancer | 3-dimensional c... | 18 Years - | Canadian Cancer Trials Group | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00006378 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients | NCT00030771 | Lung Cancer | Chemotherapy Radiotherapy Surgery | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00054392 | Lung Cancer | carboplatin gemcitabine hyd... paclitaxel | 18 Years - | Fox Chase Cancer Center | |
| Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | NCT00004859 | Lung Cancer | carboplatin paclitaxel thalidomide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00951444 | Lung Cancer | dalotuzumab carboplatin gemcitabine hyd... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | NCT00776100 | Lung Cancer | clinical observ... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | NCT00003117 | Lung Cancer | carboplatin paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | NCT00398385 | Lung Cancer | cisplatin gemcitabine hyd... adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00118183 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Malignant Pleur... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | docetaxel cetuximab bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | NCT00002823 | Lung Cancer | cisplatin etoposide vinblastine sul... vindesine vinorelbine tar... radiation thera... | 18 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | NCT01958372 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | soy isoflavones cisplatin etoposide pemetrexed diso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | NCT00003117 | Lung Cancer | carboplatin paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00499447 | Lung Cancer | radiofrequency ... radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer | NCT00499330 | Lung Cancer | lobectomy segmentectomy o... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00040794 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | paclitaxel carboplatin gefitinib radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002642 | Lung Cancer | cisplatin etoposide conventional su... low-LET cobalt-... | 18 Years - | SWOG Cancer Research Network | |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00368992 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cetuximab paclitaxel bevacizumab | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT01041781 | Lung Cancer | carboplatin celecoxib gemcitabine hyd... pemetrexed diso... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer | NCT00080938 | Lung Cancer Metastatic Canc... | Temozolomide Radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT01557959 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Non-small Cell ... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cisplatin pegfilgrastim erlotinib hydro... laboratory biom... polymorphism an... pharmacogenomic... genetic linkage... docetaxel | 18 Years - | Wake Forest University Health Sciences | |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00368992 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cetuximab paclitaxel bevacizumab | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | NCT01958372 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | soy isoflavones cisplatin etoposide pemetrexed diso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00547443 | Lung Cancer | carboplatin paclitaxel sorafenib tosyl... radiation thera... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00036920 | Lung Cancer | canfosfamide hy... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | NCT00979212 | Lung Cancer | panitumumab carboplatin paclitaxel surgery | 18 Years - | Radiation Therapy Oncology Group | |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | NCT00049543 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... | gefitinib placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy | NCT01208064 | Lung Cancer | pazopanib hydro... laboratory biom... pharmacogenomic... pharmacological... quality-of-life... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00550537 | Lung Cancer | bevacizumab carboplatin erlotinib hydro... paclitaxel gene expression... protein express... proteomic profi... laboratory biom... | 18 Years - 120 Years | Vanderbilt-Ingram Cancer Center | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | NCT00006004 | Lung Cancer | carboplatin cisplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors | NCT05194735 | Gynecologic Can... Colorectal Canc... Pancreatic Canc... Non-small Cell ... Cholangiocarcin... Ovarian Cancer Endometrial Can... Ovarian Carcino... Ovary Neoplasm Squamous Cell L... Adenocarcinoma ... Adenosquamous C... | Neoantigen spec... Aldesleukin (IL... | 18 Years - | Alaunos Therapeutics | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab | NCT00387374 | Adenosquamous C... Drug/Agent Toxi... Hemoptysis Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | bevacizumab paclitaxel carboplatin radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) | NCT01059188 | Lung Cancer | cetuximab cisplatin docetaxel Radiotherapy Surgery | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00798603 | Lung Cancer | bevacizumab carboplatin pemetrexed diso... | 70 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00526890 | Lung Cancer | selenomethionin... carboplatin paclitaxel laboratory biom... radiation thera... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | NCT00006004 | Lung Cancer | carboplatin cisplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | NCT00006004 | Lung Cancer | carboplatin cisplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00033722 | Lung Cancer | folic acid lometrexol | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00951444 | Lung Cancer | dalotuzumab carboplatin gemcitabine hyd... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer | NCT00003685 | Fatigue Lung Cancer Nausea and Vomi... Pain Pulmonary Compl... Quality of Life | fatigue assessm... nausea and vomi... pain therapy quality-of-life... radiation thera... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | NCT00049543 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... | gefitinib placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00033722 | Lung Cancer | folic acid lometrexol | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00454194 | Lung Cancer | pemetrexed diso... sorafenib tosyl... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer | NCT00499330 | Lung Cancer | lobectomy segmentectomy o... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00025285 | Lung Cancer | carboplatin irinotecan hydr... thalidomide | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00040794 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | paclitaxel carboplatin gefitinib radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
